South Windsor, CT (PRWEB) September 09, 2013
Oxford Performance Materials (OPM) is pleased to announce the creation of a new manufacturing facility in South Windsor, CT. The facility is in close proximity to OPM’s current headquarters and manufacturing facility. This region of Connecticut, long known for its advanced subtractive manufacturing technologies, is now rapidly becoming a global leader in additive manufacturing. "It has always been our intention to pivot from biomedical 3D printing to Mission Critical aerospace and industrial structures," said Scott DeFelice, President and CEO of OPM. “This new facility will bring together world class technologies and capabilities in order to service the exacting demands of our customers in the fast evolving 3D printing marketplace."
The new OPM facility has been constructed to house up to six additional laser sintering 3D printers. The first of which, an EOSINT P 800, is scheduled to be installed this fall. This will make OPM the only firm in the world with two EOSINT P 800 3D printers capable of printing high performance thermoplastics such as the firm’s proprietary OXPEKK® (PEKK) polymer. The facility will be used for the production of additively manufactured industrial and aerospace parts as well as research and development. To support customer requirements, the operation will include various processing and assembly capacities.
In order to take full advantage of 3D printing technologies, the firm will offer finite element analysis and design service to aid the customer in component optimization. The facility will have AS9100C quality management systems and be ITAR compliant.
OPM operates at the intersection of high performance polymers, additive manufacturing technologies, and the creation of structures for the biomedical and aerospace sectors. The firm currently has four operating divisions: Biomedical Devices and Parts, Biomedical Raw Materials, Industrial Parts, and Metrology Sciences. OPM was selected to participate in the National Additive Manufacturing Innovation Institute (NAMII) in 2012. OPM has obtained ISO 13485:2003 and ISO 9001:2008/AS9100C certificates and received FDA clearance in February 2013 for the OsteoFab™ Patient Specific Cranial Device.